Struggling DNA testing firm 23andMe to be bought for $256m
Pharma giant Regeneron to buy 23andMe and its customers’ data for $256M
US doctors rewrite DNA of infant with severe genetic disorder in medical first | Gene-editing breakthrough has potential to treat array of devastating genetic diseases soon after birth, scientists say
